Discontinued — last reported Q1 '20
Products & Services · Proceeds From License Agreement
Developmental Performance Milestones — Proceeds From License Agreement
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityVolatile
First reportedQ1 2019
Last reportedQ1 2020
How to read this metric
An increase indicates successful execution of R&D programs and the validation of proprietary technology, while a decrease may suggest delays in clinical development or the completion of milestone-heavy phases of a partnership.
Detailed definition
This metric represents revenue recognized from contractual milestone payments triggered by the successful achievement of...
Peer comparison
Similar to 'milestone revenue' or 'license fee revenue' reported by other biotechnology and diagnostic firms, which often fluctuate based on the timing of clinical trial results or regulatory filings.
Metric ID:
ntra_segment_developmental_performance_milestones_proceeds_from_license_agreementSimilar Metrics at Other Companies
Frequently Asked Questions
- What does developmental performance milestones — proceeds from license agreement mean?
- Revenue earned from achieving specific research or development goals defined in a licensing agreement.